CNE000000KV1
CNE000000KV1
NANJING PHARMACEUTICAL GP CO LT
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 54.963.277.450 | 53.696.173.896 | 2.4% |
| Cost of Revenue | 51.580.940.619 | 50.323.077.943 | 2.5% |
| Gross Profit | 3.382.336.831 | 3.373.095.953 | 0.3% |
| 1.848.736.726 | 1.782.069.226 | 3.7% | |
| Operating Income | 1.533.600.104 | 1.591.026.727 | 3.6% |
| Pretax Income | 1.157.627.934 | 1.003.395.389 | 15.4% |
| Net Income Common Stockholders | 624.834.795 | 570.627.553 | 9.5% |
| -- | -- | -- | |
| -- | -- | -- |